Published in J Chromatogr B Biomed Appl on April 12, 1996
High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids. J Chromatogr (1985) 1.48
Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum. Br J Clin Pharmacol (1985) 1.48
Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum. Br J Clin Pharmacol (1985) 1.22
Pharmacokinetics of the enantiomers of acenocoumarol in man. Br J Clin Pharmacol (1981) 1.19
Absolute bioavailability of letrozole in healthy postmenopausal women. Biopharm Drug Dispos (1997) 1.17
Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.16
Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol (1985) 1.09
Effect of food on the bioavailability of triclabendazole in patients with fascioliasis. Br J Clin Pharmacol (1998) 1.04
Determination of metoprolol and its alpha-hydroxylated metabolite in human plasma by high-performance liquid chromatography. J Chromatogr (1984) 1.00
Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function. J Clin Pharmacol (1997) 0.95
Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption. Br J Clin Pharmacol (1985) 0.95
Quantitative determination of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection. J Chromatogr (1985) 0.94
High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection. J Chromatogr B Biomed Appl (1996) 0.94
Determination of two metoprolol metabolites in human urine by high-performance liquid chromatography. J Chromatogr (1984) 0.94
Quantitative assay of diclofenac in biological material by gas-liquid chromatography. J Chromatogr (1975) 0.93
Pharmacokinetics of valsartan in patients with liver disease. Clin Pharmacol Ther (1997) 0.93
Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release. Br J Clin Pharmacol (1985) 0.91
Investigation of drug absorption from the gastrointestinal tract of man. V. Effect of the beta-adrenoceptor antagonist, metoprolol, on postprandial gastric function. Br J Clin Pharmacol (1985) 0.90
[The percutaneous absorption of diclofenac]. Arzneimittelforschung (1986) 0.90
Determination of artemether and its metabolite, dihydroartemisinin, in plasma by high-performance liquid chromatography and electrochemical detection in the reductive mode. J Chromatogr B Biomed Sci Appl (1997) 0.90
Gas chromatographic determination of amantadine hydrochloride (Symmetrel) in human plasma and urine. J Chromatogr (1980) 0.88
Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations. Am Heart J (1989) 0.88
Gas chromatographic determination of oxprenolol in human plasma. J Chromatogr (1983) 0.88
Development, application and comparison of an enzyme immunoassay and a high-performance liquid chromatography method for the determination of the aromatase inhibitor CGS 20,267 in biological fluids. J Pharm Sci (1994) 0.88
High-performance liquid chromatographic analysis of the sulfide metabolite of sulfinpyrazone in plasma. J Chromatogr (1982) 0.87
Gas chromatographic determination of metoprolol in human plasma. J Chromatogr (1983) 0.86
Gastric and intestinal absorption of oxprenolol in humans. J Clin Pharmacol (1987) 0.86
Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel. Biopharm Drug Dispos (1994) 0.85
Fast liquid chromatography for the determination of drugs in plasma and combination with liquid-solid extraction in a fully automated system. J Chromatogr (1992) 0.85
The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteers. Biopharm Drug Dispos (1998) 0.84
Automated and sensitive method for the determination of formoterol in human plasma by high-performance liquid chromatography and electrochemical detection. J Chromatogr B Biomed Sci Appl (1997) 0.84
Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration. Biopharm Drug Dispos (1997) 0.84
Total knee arthroplasty three-dimensional kinematic estimation prevision. From a two-dimensional fluoroscopy acquired dynamic model. Orthop Traumatol Surg Res (2011) 0.82
Determination of oxprenolol in human plasma by high-performance liquid chromatography, in comparison with gas chromatography and gas chromatography-mass spectrometry. J Chromatogr (1985) 0.82
Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer. Clin Cancer Res (1999) 0.82
Gas chromatographic determination of phenazone derivatives in human plasma. II. Propyphenazone. J Chromatogr (1978) 0.82
Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol. Eur J Clin Pharmacol (1997) 0.82
The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. Br J Clin Pharmacol (1993) 0.81
Determination of clomipramine or imipramine and their mono-demethylated metabolites in human blood or plasma by high-performance liquid chromatography. J Chromatogr (1981) 0.81
Cemented total hip stem design influence on adaptative cortical thickness and femoral morphology. Orthop Traumatol Surg Res (2010) 0.81
GLC determination of free and conjugated triclosan in human plasma and urine. J Pharm Sci (1977) 0.80
The effect of age on the pharmacokinetics of valsartan. Biopharm Drug Dispos (1998) 0.80
Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects. Eur J Clin Pharmacol (1994) 0.79
Simultaneous determination of imipramine and its metabolite desipramine in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B Biomed Sci Appl (1997) 0.79
Determination of clomipramine and desmethyl-clomipramine in plasma or urine by the double-radioisotope derivative technique. Clin Chem (1976) 0.79
The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites. Eur J Clin Pharmacol (1994) 0.78
Total talar fracture - long-term results of internal fixation of talar fractures. A multicentric study of 114 cases. Orthop Traumatol Surg Res (2012) 0.78
Pharmacokinetics of terbinafine and five known metabolites in children, after oral administration. Biopharm Drug Dispos (1998) 0.78
Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: application to diclofenac. Br J Clin Pharmacol (1989) 0.78
Colonoscopy in the investigation of drug absorption in healthy volunteers. Gastrointest Endosc (1985) 0.78
Total talar fracture - inter- and intra-observer reproducibility of two classification systems (Hawkins and AO) for central talar fractures. Orthop Traumatol Surg Res (2012) 0.78
GLC determination of alpha- and beta-tribenosides in human plasma. J Pharm Sci (1980) 0.78
Automated microanalysis of carbamazepine and its epoxide and trans-diol metabolites in plasma by column liquid chromatography. J Chromatogr (1992) 0.77
Diclofenac sodium-chlormezanone poisoning. Eur J Clin Pharmacol (1984) 0.77
Determination of diclofenac in plasma and urine by capillary gas chromatography-mass spectrometry with possible simultaneous determination of deuterium-labelled diclofenac. J Chromatogr (1991) 0.77
Automated microanalysis of oxcarbazepine and its monohydroxy and transdiol metabolites in plasma by liquid chromatography. J Chromatogr B Biomed Appl (1994) 0.76
Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations. Eur J Drug Metab Pharmacokinet (1995) 0.76
Inter- and intra-subject variability of metoprolol kinetics after intravenous administration. Eur J Drug Metab Pharmacokinet (1995) 0.76
Pharmacokinetics of chlorthalidone in the elderly after single and multiple doses. Br J Clin Pharmacol (1983) 0.75
Influence of exercise on nitroglycerin plasma concentrations after transdermal application. Br J Clin Pharmacol (1990) 0.75
Plasma levels and pharmacokinetics of sulphinpyrazone in renal impairment during chronic treatment: a case report. Br J Clin Pharmacol (1984) 0.75
A new metabolite of diclofenac sodium in human plasma. Xenobiotica (1988) 0.75
Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk. Br J Clin Pharmacol (1984) 0.75
High-performance liquid chromatographic determination of sulphathiazole in human plasma and urine. J Chromatogr (1980) 0.75
Determination of the major metabolite of phentolamine in human plasma and urine by high-performance liquid chromatography. J Chromatogr (1981) 0.75
Gas chromatographic determination of low concentrations of benzoic acid in human plasma and urine. J Chromatogr (1980) 0.75
Pharmacokinetics of phenylbutazone in healthy subjects after oral administration of single and multiple doses. J Pharm Sci (1980) 0.75
Gas chromatographic determination of valproic acid in human plasma. J Chromatogr (1980) 0.75
Simultaneous determination of norethisterone and six metabolites in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B Biomed Appl (1995) 0.75
Determination of the two mononitrate metabolites of isosorbide dinitrate in human plasma and urine by gas chromatography with electron-capture detection. J Chromatogr (1984) 0.75
Biotransformation of tribenoside into benzoic acid in man. Eur J Drug Metab Pharmacokinet (1982) 0.75
Gas chromatographic determination of N-desmethyl-propyphenazone, a metabolite of propyphenazone, in human urine. J Chromatogr (1980) 0.75
Determination of the (+)- and (-)-enantiomers of pirprofen in human plasma by high-performance liquid chromatography. J Chromatogr (1987) 0.75
Simultaneous determination of pirprofen and its metabolite, the pyrrole derivative, in plasma by high-performance liquid chromatography. J Chromatogr (1985) 0.75
Determination of the two dinitrate metabolites of nitroglycerin in human plasma by capillary gas chromatography with electron-capture detection. J Chromatogr (1987) 0.75
Pharmacokinetics of pirprofen in children with juvenile chronic arthritis. Eur J Drug Metab Pharmacokinet (1991) 0.75
Determination of oxyphenbutazone in human plasma by high-performance liquid chromatography. J Chromatogr (1983) 0.75
[Blood concentrations of maprotiline in depressive patients]. Encephale (1989) 0.75
[Comparative elimination of pirprofen from the plasma and synovial fluid of the knee. 26 cases]. Presse Med (1983) 0.75
Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems. Methods Find Exp Clin Pharmacol (1989) 0.75
[Transport of sodium diclofenac into synovial fluid]. Therapie (1984) 0.75
Determination of acenocoumarol in human plasma by capillary gas chromatography with mass-selective detection. J Chromatogr B Biomed Appl (1994) 0.75
Gas chromatographic determination of maprotiline and its N-desmethyl metabolite in human blood using nitrogen detection. J Chromatogr (1980) 0.75
Bioequivalence assessment: a pharmaceutical industry perspective. Eur J Drug Metab Pharmacokinet (1996) 0.75
Stereospecific high-performance liquid chromatographic determination of an S(-)-benzopyran methyl ester derivative (CGP 50 068), its (-)-carboxylic acid metabolite (CGP 55 461) and the related (+)-enantiomer (CGP 54 228) in human and dog plasma. J Chromatogr B Biomed Appl (1995) 0.75
Gas chromatographic determination of phentolamine (Regitine) in human plasma and urine. J Chromatogr (1981) 0.75
Gas chromatographic determination of phenazone derivatives in human plasma. I. Aminophenazone. J Chromatogr (1978) 0.75
GLC determination of phenylbutazone in human plasma. J Pharm Sci (1978) 0.75
Gas chromatographic determination of clioquinol (Vioform) in human plasma. J Chromatogr (1981) 0.75
Gas chromatographic determination of isosorbide dinitrate in human plasma and urine. J Chromatogr (1982) 0.75
[Effect of 3 antacids on the bioavailability of pirprofen]. Therapie (1984) 0.75
Determination of isosorbide as a metabolite of isosorbide dinitrate in human urine by capillary gas chromatography with electron-capture detection. J Chromatogr (1983) 0.75
Determination of pirprofen in biological material by gas-liquid chromatography with nitrogen-specific and electron-capture detection. J Chromatogr (1984) 0.75
Renal and endocrine effects of flosulide, after single and repeated administration to healthy volunteers. Eur J Clin Pharmacol (1995) 0.75